• norsk
    • English
  • English 
    • norsk
    • English
  • Login
Browsing by Subject 
  •   Home
  • Browsing by Subject
  •   Home
  • Browsing by Subject
JavaScript is disabled for your browser. Some features of this site may not work without it.

Browsing ODA Open Digital Archive by Subject "177Lu-lilotomab satetraxetan"

  • 0-9
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • Æ
  • Ø
  • Å

Sort by:

Order:

Results:

Now showing items 1-1 of 1

  • title
  • issue date
  • submit date
  • author
  • ascending
  • descending
  • 5
  • 10
  • 20
  • 40
  • 60
  • 80
  • 100
    • Pre-dosing with lilotomab prior to therapy with 177Lu-lilotomab satetraxetan significantly increases the ratio of tumor to red marrow absorbed dose in non-Hodgkin lymphoma patients 

      Stokke, Caroline; Blakkisrud, Johan; Løndalen, Ayca; Dahle, Jostein; Martinsen, Anne Catrine Trægde; Holte, Harald; Kolstad, Arne (European Journal of Nuclear Medicine and Molecular Imaging;July 2018, Volume 45, Issue 7, Journal article; Peer reviewed, 2018-02-22)
      Purpose: 177Lu-lilotomab satetraxetan is a novel anti-CD37 antibody radionuclide conjugate for the treatment of non-Hodgkin lymphoma (NHL). Four arms with different combinations of pre-dosing and pre-treatment have been ...

      Contact Us | Send Feedback

      Privacy policy
      DSpace software copyright © 2002-2019  DuraSpace

      Service from  Unit
       

       

      Browse

      ArchiveCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsDocument TypesJournals

      My Account

      Login

      Contact Us | Send Feedback

      Privacy policy
      DSpace software copyright © 2002-2019  DuraSpace

      Service from  Unit